EichorEICHOR
Condition: Deaf Blind Synced from ClinicalTrials.gov · August 03, 2026

Recruiting studies: Deaf Blind

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Phase 1/Phase 2 · 5 location(s) · BlueRock Therapeutics · NCT06789445Monogenic Diabetes Misdiagnosed as Type 1
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT03988764Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843Stem Cell Ophthalmology Treatment Study II
NA · 4 location(s) · MD Stem Cells · NCT03011541Natural History Study of Usher Syndrome ( Light4Deaf )
Phase N/A · 4 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT04665726Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT02841553Adaptive Optics Imaging of Outer Retinal Diseases
Phase N/A · 2 location(s) · Food and Drug Administration (FDA) · NCT05355415Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Phase 1/Phase 2 · 3 location(s) · AAVantgarde Bio Srl · NCT06591793Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Phase N/A · 1 location(s) · Okuvision GmbH · NCT07548944GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With P
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06475651
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.